Data Set for Reporting of Endometrial Carcinomas: Recommendations From the International Collaboration on Cancer Reporting (ICCR) Between United Kingdom, United States, Canada, and Australasia
暂无分享,去创建一个
N. Hacker | C. Otis | R. Zaino | W. McCluggage | L. Hirschowitz | N. Mulvany | M. Duggan | N. Wilkinson | Terry Colgan | F. Path
[1] C Blake Gilks,et al. Patterns of p53 immunoreactivity in endometrial carcinomas: ‘all or nothing’ staining is of importance , 2011, Histopathology.
[2] H. Boezen,et al. Molecular markers and clinical behavior of uterine carcinosarcomas: focus on the epithelial tumor component , 2011, Modern Pathology.
[3] K. Chao,et al. The incidence of isolated para-aortic nodal metastasis in completely staged endometrial cancer patients. , 2011, Gynecologic oncology.
[4] E. Oliva,et al. Significant Variation in the Assessment of Cervical Involvement in Endometrial Carcinoma: An Interobserver Variation Study , 2011, The American journal of surgical pathology.
[5] B. Clarke,et al. Histologic Artifacts in Abdominal, Vaginal, Laparoscopic, and Robotic Hysterectomy Specimens: A Blinded, Retrospective Review , 2011, The American journal of surgical pathology.
[6] F. Gao,et al. Lower Uterine Segment Involvement is Associated with Poor Outcomes in Early-Stage Endometrioid Endometrial Carcinoma , 2011, Annals of Surgical Oncology.
[7] Ruchira Singh,et al. BMI and Uterine Size: Is There Any Relationship? , 2010, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[8] M. Stoler,et al. Cervical Stromal Invasion Predicting Survival in Endometrial Cancer , 2010, Obstetrics and gynecology.
[9] S. Kehoe,et al. Which Staging System to Use for Gynecological Cancers: Recommendations for Practice in the United Kingdom , 2010, International Journal of Gynecologic Cancer.
[10] M. Stoler,et al. The Significance of Tumor Involved Adenomyosis in Otherwise Low-stage Endometrioid Adenocarcinoma , 2010, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[11] S. Kehoe,et al. Which staging system to use for gynaecological cancers: a survey with recommendations for practice in the UK , 2010, Journal of Clinical Pathology.
[12] A. Obermair,et al. Evaluation of Tumor-Free Distance and Depth of Myometrial Invasion as Prognostic Factors for Lymph Node Metastases in Endometrial Cancer , 2010, International Journal of Gynecologic Cancer.
[13] W. McCluggage,et al. Mullerian Adenosarcoma of the Female Genital Tract , 2010, Advances in anatomic pathology.
[14] Seyed Shahabeddin Sadr,et al. Study of the normal internal organ weights in Tehran's population. , 2010, Journal of forensic and legal medicine.
[15] S. Pecorelli. Corrigendum to “Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium” , 2010 .
[16] W. McCluggage. Problematic areas in the reporting of endometrial carcinomas in hysterectomy specimens , 2009 .
[17] C. Gilks,et al. Protocol for the Examination of Specimens From Patients With Carcinoma of the Endometrium , 2009 .
[18] W. McCluggage,et al. WT1, p53 and hormone receptor expression in uterine serous carcinoma , 2009, Histopathology.
[19] I. Shih,et al. Utility of p16 Expression for Distinction of Uterine Serous Carcinomas From Endometrial Endometrioid and Endocervical Adenocarcinomas: Immunohistochemical Analysis of 201 Cases , 2009, The American journal of surgical pathology.
[20] E. Anteby,et al. Lower uterine segment involvement is associated with adverse outcome in patients with stage I endometroid endometrial cancer: results of a multicenter study. , 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[21] A. Secord,et al. Multicenter analysis of recurrence and survival in stage IIIA endometrial cancer. , 2009, Gynecologic oncology.
[22] K. Garg,et al. Lynch syndrome (hereditary non-polyposis colorectal cancer) and endometrial carcinoma , 2009, Journal of Clinical Pathology.
[23] Rebecca Tooher,et al. Extending an evidence hierarchy to include topics other than treatment: revising the Australian 'levels of evidence' , 2009, BMC medical research methodology.
[24] E. Oliva,et al. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion. , 2009, Gynecologic oncology.
[25] K. Kosarin,et al. Selection of Endometrial Carcinomas for DNA Mismatch Repair Protein Immunohistochemistry Using Patient Age and Tumor Morphology Enhances Detection of Mismatch Repair Abnormalities , 2009, The American journal of surgical pathology.
[26] E. Myers,et al. Cost effectiveness of a test to detect metastases for endometrial cancer. , 2009, Gynecologic oncology.
[27] A. Malpica,et al. Vascular Pseudoinvasion in Laparoscopic Hysterectomy Specimens for Endometrial Carcinoma: A Grossing Artifact? , 2009, The American journal of surgical pathology.
[28] L. Akslen,et al. Importance of tumour cell invasion in blood and lymphatic vasculature among patients with endometrial carcinoma , 2009, Histopathology.
[29] D. Cohn,et al. Prospective evaluation of prognostic significance of the tumor-free distance from uterine serosa in surgically staged endometrial adenocarcinoma. , 2009, Gynecologic oncology.
[30] R. Soslow,et al. Application of immunohistochemistry to gynecologic pathology. , 2009, Archives of pathology & laboratory medicine.
[31] D. Bodurka,et al. Carcinoma of the lower uterine segment: a newly described association with Lynch syndrome. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] A. Gammerman,et al. Predicting Clinical Outcome in Patients Diagnosed with Synchronous Ovarian and Endometrial Cancer , 2008, Clinical Cancer Research.
[33] James V. Little,et al. Vascular “Pseudo Invasion” in Laparoscopic Hysterectomy Specimens: A Diagnostic Pitfall , 2008, The American journal of surgical pathology.
[34] O. Fadare,et al. Endometrial Glandular Dysplasia (EmGD): morphologically and biologically distinctive putative precursor lesions of Type II endometrial cancers , 2008, Diagnostic pathology.
[35] Wenxin Zheng,et al. Endometrial glandular dysplasia and endometrial intraepithelial neoplasia , 2008, Current opinion in obstetrics & gynecology.
[36] M. Deveci,et al. Does the localisation of tumour at stage I endometrial endometrioid adenocarcinoma have an impact on invasion of the tumour and individualisation of the surgical procedure? , 2008, European journal of gynaecological oncology.
[37] R. Barakat,et al. Prognostic Features of Surgical Stage I Uterine Carcinosarcoma , 2007, The American journal of surgical pathology.
[38] Richard G. Moore,et al. Lower uterine segment involvement as a predictor for lymph node spread in endometrial carcinoma. , 2007, Gynecologic oncology.
[39] J. Berek,et al. Lymphadenectomy in endometrioid uterine cancer staging , 2007, Cancer.
[40] A. Evans,et al. Peritoneal keratin granulomas complicating endometrial carcinoma: a report of two cases and review of the literature , 2007, International Journal of Gynecologic Cancer.
[41] R. Soslow,et al. Difficulties in Assessing the Depth of Myometrial Invasion in Endometrial Carcinoma , 2007, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[42] P. Disaia,et al. Margin distance and other clinico-pathologic prognostic factors in vulvar carcinoma: a multivariate analysis. , 2007, Gynecologic oncology.
[43] Y. Saga,et al. Omental metastases in clinical stage I endometrioid adenocarcinoma , 2007, International Journal of Gynecologic Cancer.
[44] A. Malpica,et al. Undifferentiated carcinoma of the endometrium: a review. , 2007, Pathology.
[45] J. Davis,et al. Occurrence of Endometrial Glandular Dysplasia Precedes Uterine Papillary Serous Carcinoma , 2007, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[46] E. Hauth,et al. MR imaging of the uterus and cervix in healthy women: Determination of normal values , 2007, European Radiology.
[47] A. Berchuck,et al. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology. , 2006, Gynecologic oncology.
[48] A. Malpica,et al. Endometrioid Carcinoma Simultaneously Involving the Uterus and the Fallopian Tube: A Clinicopathologic Study of 13 Cases , 2006, The American journal of surgical pathology.
[49] T. Lesnick,et al. Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients. , 2006, Gynecologic oncology.
[50] D. Aoki,et al. Analysis of clinicopathologic factors predicting para-aortic lymph node metastasis in endometrial cancer , 2005, International Journal of Gynecologic Cancer.
[51] S. Mount,et al. Laparoscopic surgery does not increase the positive peritoneal cytology among women with endometrial carcinoma. , 2006, Gynecologic oncology.
[52] P. Maisonneuve,et al. Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[53] C. Powell. Occult ovarian cancer at the time of risk-reducing salpingo-oophorectomy. , 2006, Gynecologic oncology.
[54] D. Faratian,et al. A review of the pathology and management of uterine papillary serous carcinoma and correlation with outcome , 2005, International Journal of Gynecologic Cancer.
[55] S. Kalloger,et al. Description of a Novel System for Grading of Endometrial Carcinoma and Comparison With Existing Grading Systems , 2005, The American journal of surgical pathology.
[56] R. Walker,et al. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs , 2005 .
[57] J. McKenney,et al. Endometrial Adenocarcinoma Associated With Subtle Lymph-Vascular Space Invasion and Lymph Node Metastasis: A Histologic Pattern Mimicking Intravascular and Sinusoidal Histiocytes , 2005, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[58] I. Jacobs,et al. A molecular genetic and statistical approach for the diagnosis of dual-site cancers. , 2004, Journal of the National Cancer Institute.
[59] H. Verkooijen,et al. Positive peritoneal cytology in early-stage endometrial cancer does not influence prognosis , 2004, British Journal of Cancer.
[60] Jaime Prat,et al. Prognostic parameters of endometrial carcinoma. , 2004, Human pathology.
[61] L. Akslen,et al. Prognostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma of endometrioid type , 2004, Histopathology.
[62] W. McCluggage,et al. A Critical Appraisal of the Value of Immunohistochemistry in Diagnosis of Uterine Neoplasms , 2004, Advances in anatomic pathology.
[63] Paul J. L. Zhang,et al. WT1 is Differentially Expressed in Serous, Endometrioid, Clear Cell, and Mucinous Carcinomas of the Peritoneum, Fallopian Tube, Ovary, and Endometrium , 2004, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[64] A. Ayhan,et al. The long-term survival of women with surgical stage II endometrioid type endometrial cancer. , 2004, Gynecologic oncology.
[65] S. de Blok,et al. Does diagnostic hysteroscopy in patients with stage I endometrial carcinoma cause positive peritoneal washings? , 2004, Gynecologic oncology.
[66] W. McCluggage. WT1 is of value in ascertaining the site of origin of serous carcinomas within the female genital tract. , 2004, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[67] W. van Putten,et al. Prognostic significance and interobserver variability of histologic grading systems for endometrial carcinoma , 2004, Cancer.
[68] W. McCluggage,et al. WT‐1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma , 2004, Histopathology.
[69] P. Clement,et al. Endometrioid Carcinoma of the Uterine Corpus: A Review of Its Pathology With Emphasis on Recent Advances and Problematic Aspects , 2002, Advances in anatomic pathology.
[70] N. Ramirez,et al. Is there a prognostic difference between depth of myometrial invasion and the tumor-free distance from the uterine serosa in endometrial cancer? , 2003, Gynecologic oncology.
[71] R. Scully,et al. Unusual Epithelial and Stromal Changes in Myoinvasive Endometrioid Adenocarcinoma: A Study of Their Frequency, Associated Diagnostic Problems, and Prognostic Significance , 2003, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[72] S. Murata,et al. Wilms Tumor Gene Immunoreactivity in Primary Serous Carcinomas of the Fallopian Tube, Ovary, Endometrium, and Peritoneum , 2003, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[73] V. Sumathi,et al. Uterine serous carcinoma and endometrial intraepithelial carcinoma arising in endometrial polyps: report of 5 cases, including 2 associated with tamoxifen therapy. , 2003, Human pathology.
[74] M. J. Webb,et al. Endometrial cancer: predictors of peritoneal failure. , 2003, Gynecologic oncology.
[75] T. Kasamatsu,et al. Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterus , 2003, British Journal of Cancer.
[76] J. Seidman,et al. Evaluation of the Relationship Between Adenosarcoma and Carcinosarcoma and a Hypothesis of the Histogenesis of Uterine Sarcomas , 2003, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[77] H. Kuramoto,et al. Parametrial spread is a prognostic factor in endometrial carcinoma. , 2003, European journal of gynaecological oncology.
[78] H. Hollema,et al. Vulvar carcinoma , 2002, Cancer.
[79] A. Obermair,et al. The impact of positive peritoneal washings and serosal and adnexal involvement on survival in patients with stage IIIA uterine cancer. , 2002, Gynecologic oncology.
[80] W. McCluggage,et al. Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas , 2002, International Journal of Gynecologic Cancer.
[81] G. Lockwood,et al. Stage II endometrial carcinoma: prognostic factors and risk classification in 170 patients. , 2002, International journal of radiation oncology, biology, physics.
[82] X. Matías-Guiu,et al. Clonality Analysis in Synchronous or Metachronous Tumors of the Female Genital Tract , 2002, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[83] P. Clement,et al. Endometrioid Carcinoma of the Uterine Corpus: A Review of Its Pathology With Emphasis on Recent Advances and Problematic Aspects , 2002, Advances in anatomic pathology.
[84] W. McCluggage,et al. Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas? , 2002, Journal of clinical pathology.
[85] N. Goldstein,et al. WT1 immunoreactivity in uterine papillary serous carcinomas is different from ovarian serous carcinomas. , 2002, American journal of clinical pathology.
[86] L. Jordan,et al. Clinicopathological study of the pattern and significance of cervical involvement in cases of endometrial adenocarcinoma , 2002, International Journal of Gynecologic Cancer.
[87] E. Berg,et al. World Health Organization Classification of Tumours , 2002 .
[88] S. Altunyurt,et al. Omentectomy, peritoneal biopsy and appendectomy in patients with clinical stage I endometrial carcinoma , 2001, International Journal of Gynecologic Cancer.
[89] G. Moreno-Bueno,et al. &bgr;-Catenin Expression Pattern, &bgr;-Catenin Gene Mutations, and Microsatellite Instability in Endometrioid Ovarian Carcinomas and Synchronous Endometrial Carcinomas , 2001, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[90] A. García,et al. Molecular pathology of endometrial hyperplasia and carcinoma. , 2001, Human pathology.
[91] R. Barakat,et al. High incidence of positive peritoneal cytology in low-risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy. , 2001, Gynecologic oncology.
[92] B. Gilks,et al. Early stage uterine papillary serous carcinoma of the endometrium , 2001, Cancer.
[93] S. Sekiya,et al. Significance of perivascular lymphocytic infiltrates in endometrial carcinoma. , 2001, Cancer.
[94] J. van der Palen,et al. Treatment results in women with clinical stage I and pathologic stage II endometrial carcinoma , 2000, International Journal of Gynecologic Cancer.
[95] R. A’Hern,et al. An audit of outcome of adjuvant post-operative radiotherapy for 52 women with stage II carcinoma of the endometrium. , 2000, British Journal of Radiology.
[96] R. Kurman,et al. A Binary Architectural Grading System for Uterine Endometrial Endometrioid Carcinoma Has Superior Reproducibility Compared With FIGO Grading and Identifies Subsets of Advance-Stage Tumors With Favorable and Unfavorable Prognosis , 2000, The American journal of surgical pathology.
[97] R. Petersen,et al. Stage 3B adenocarcinoma of the endometrium: a clinicopathologic study. , 2000, Gynecologic oncology.
[98] M. Sherman,et al. Minimal uterine serous carcinoma: diagnosis and clinicopathologic correlation. , 2000, The American journal of surgical pathology.
[99] P. Disaia,et al. Significance of true surgical pathologic staging: a Gynecologic Oncology Group Study. , 1999, American journal of obstetrics and gynecology.
[100] D. O'connor,et al. An analysis of two versus three grades for endometrial carcinoma. , 1999, Gynecologic oncology.
[101] G. Eltabbakh,et al. Survival of women with surgical stage II endometrial cancer. , 1999, Gynecologic oncology.
[102] A. Mundt,et al. The significance of adnexal involvement in endometrial carcinoma. , 1999, Gynecologic oncology.
[103] T. Kaku,et al. Predicting pelvic lymph node metastasis in endometrial carcinoma. , 1999, Gynecologic oncology.
[104] M. Hendrickson,et al. Diffusely infiltrative endometrial adenocarcinoma: an adenoma malignum pattern of myoinvasion. , 1999, The American journal of surgical pathology.
[105] N. Katsumata,et al. Clinicopathological factors predicting retroperitoneal lymph node metastasis and survival in endometrial cancer. , 1998, Japanese journal of clinical oncology.
[106] R. Kurman,et al. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression. , 1998, Human pathology.
[107] K. Shroyer,et al. Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumors. , 1997, Cancer research.
[108] I. Konishi,et al. Parametrial involvement in endometrial carcinomas: its incidence and correlation with other histological parameters. , 1996, Gynecologic oncology.
[109] A. Behrens,et al. Peritoneal washing cytology in gynecologic cancers: long-term follow-up of 355 patients. , 1996, Journal of the National Cancer Institute.
[110] K. Shroyer,et al. Application of clonal analysis. Differential diagnosis for synchronous primary ovarian and endometrial cancers and metastatic cancer. , 1996, American journal of clinical pathology.
[111] S. Wellek,et al. Sonographic size of uterus and ovaries in pre‐ and postmenopausal women , 1996, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[112] H. Hoshiai,et al. The prognostic significance of vascular invasion by endometrial carcinoma. , 1996, Cancer.
[113] M. Sherman,et al. Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation. , 1995, Human pathology.
[114] M. Pieretti,et al. Loss of heterozygosity and genomic instability in synchronous endometrioid tumors of the ovary and endometrium , 1995, Cancer.
[115] F. Kate,et al. Extracapsular growth of lymph node metastases in squamous cell carcinoma of the vulva. The impact on recurrence and survival , 1995, Cancer.
[116] W. R. Hart,et al. Carcinosarcomas of the female genital tract. A pathologic study of 29 metastatic tumors: further evidence for the dominant role of the epithelial component and the conversion theory of histogenesis. , 1995, The American journal of surgical pathology.
[117] M. Carcangiu,et al. Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium: comparison of clinicopathologic features and survival. , 1995, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[118] R. Kurman,et al. The utility of the revised International Federation of Gynecology and Obstetrics histologic grading of endometrial adenocarcinoma using a defined nuclear grading system. A gynecologic oncology group study , 1995, Cancer.
[119] T. Kaku,et al. Reassessment of Myometrial Invasion in Endometrial Carcinoma , 1994, Obstetrics and gynecology.
[120] P. Hantschmann,et al. Prognostic factors that predict pelvic lymph node metastasis from endometrial carcinoma , 1994, Cancer.
[121] T. Frank,et al. Synchronous dual primary ovarian and endometrial carcinomas , 1993, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[122] A. Ayhan,et al. Correlation between clinical and histopathologic risk factors and lymph node metastases in early endometrial cancer (a multivariate analysis of 183 cases) , 1993, International Journal of Gynecologic Cancer.
[123] K. Barwick,et al. Endometrial adenocarcinoma involving adenomyosis without true myometrial invasion is characterized by frequent preceding estrogen therapy, low histologic grades, and excellent prognosis. , 1993, Gynecologic oncology.
[124] R. Woolas,et al. Mixed serous—endometrioid carcinoma of the uterus: pathologic and cytopathologic analysis of a high-risk endometrial carcinoma , 1993, International Journal of Gynecologic Cancer.
[125] H. Homesley,et al. Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extrauterine disease. , 1992, Gynecologic oncology.
[126] A. Ayhan,et al. Synchronous primary malignancies of the female genital tract. , 1992, European journal of obstetrics, gynecology, and reproductive biology.
[127] M. Sherman,et al. Uterine Serous Carcinoma A Morphologically Diverse Neoplasm With Unifying Clinicopathologic Features , 1992, The American journal of surgical pathology.
[128] M. Sideri,et al. Prognostic value of pathological patterns of lymph node positivity in squamous cell carcinoma of the vulva stage III and IVA FIGO. , 1992, Gynecologic oncology.
[129] J. Berek,et al. Characteristics of patients with small-volume residual ovarian cancer unresponsive to cisplatin-based ip chemotherapy: lessons learned from a Gynecologic Oncology Group phase II trial of ip cisplatin and recombinant alpha-interferon. , 1992, Gynecologic oncology.
[130] C. Morrow,et al. Relationship between surgical‐pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A Gynecologic Oncology Group study , 1991, Gynecologic oncology.
[131] X. Matías-Guiu,et al. Simultaneous carcinoma involving the endometrium and the ovary. A clinicopathologic, immunohistochemical, and DNA flow cytometric study of 18 cases , 1991, Cancer.
[132] D. Gal,et al. Lymphvascular space involvement--a prognostic indicator in endometrial adenocarcinoma. , 1991, Gynecologic oncology.
[133] M. Piver,et al. Prognostic significance of the extent of cervical involvement by endometrial cancer. , 1991, Gynecologic oncology.
[134] D. Herbold,et al. The significance of squamous differentiation in endometrial carcinoma , 1988 .
[135] J. Heaps,et al. Surgical‐pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva , 1991, Gynecologic oncology.
[136] M. Tompkins,et al. Prognostic value of peritoneal cytology in endometrial carcinoma , 1990, Gynecologic oncology.
[137] W. Lawrence,et al. Endometrial adenocarcinoma with variable-level myometrial involvement limited to adenomyosis: a clinicopathologic study of 23 cases. , 1990, Gynecologic oncology.
[138] H. Tilly,et al. Effect of chemotherapy on resting energy expenditure in patients with non‐Hodgkin's lymphoma results of a sequential study , 1990, Cancer.
[139] E. Silva,et al. Serous carcinoma in endometrial polyps. , 1990, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[140] P. O'Brien,et al. Evaluation of unfavorable histologic subtypes in endometrial adenocarcinoma. , 1990, American journal of obstetrics and gynecology.
[141] N. Sneige,et al. The Prognostic Significance of Peritoneal Cytology for Stage I Endometrial Cancer , 1989, Obstetrics and gynecology.
[142] W. Lichtenegger,et al. 10 Operative anatomy and technique of radical parametrial resection in the surgical treatment of cervical cancer , 1988 .
[143] W. Lichtenegger,et al. Operative anatomy and technique of radical parametrial resection in the surgical treatment of cervical cancer. , 1988, Bailliere's clinical obstetrics and gynaecology.
[144] M. Melhem,et al. Mucinous Adenocarcinoma of the Endometrium: A Clinico-Pathological Review of 18 Cases , 1988 .
[145] B. Bundy,et al. Surgical pathologic spread patterns of endometrial cancer: A gynecologic oncology group study , 1987, Cancer.
[146] J. van Nagell,et al. The prognostic significance of lymph‐vascular space invasion in stage I endometrial cancer , 1985, Cancer.
[147] E. Unger,et al. Synchronous carcinomas of the uterine corpus and ovary. , 1984, Gynecologic oncology.
[148] S. Ivarsson,et al. Ultrasonography of the pelvic organs in prepubertal and postpubertal girls. , 1983, Archives of disease in childhood.
[149] R. Berkowitz,et al. 45,X complete hydatidiform mole. , 1982, Gynecologic oncology.
[150] R. Kempson,et al. Uterine papillary serous carcinoma: A highly malignant form of endometrial adenocarcinoma , 1982, The American journal of surgical pathology.
[151] W. Creasman,et al. THE PROGNOSTIC VALUE OF PERITONEAL CYTOLOGY IN GYNECOLOGIC MALIGNANT DISEASE , 1972 .
[152] W. Creasman,et al. The prognostic value of peritoneal cytology in gynecologic malignant disease. , 1971, American journal of obstetrics and gynecology.
[153] Langlois Pl. The size of the normal uterus. , 1970 .
[154] P. Langlois. The size of the normal uterus. , 1970, The Journal of reproductive medicine.
[155] E. Davis. CARCINOMA OF THE CORPUS UTERI. , 1964, American journal of obstetrics and gynecology.